MUNICH, GERMANY / ACCESSWIRE / July 26, 2018 / Definiens AG, the leader in Tissue Phenomics® is very pleased to announce the appointment of Mr. Markus Schunk as Chief Operating Officer, a Management ...
MUNICH, GERMANY / ACCESSWIRE / November 13, 2017 / Definiens, the leader in Tissue Phenomics® announced the strengthening of its global commercial leadership team by appointing Jacques Corriveau as ...
Definiens, the number one Enterprise Image Intelligence™ company, has announced the introduction of a new multi-dimensional image analysis platform. Software applications built on Definiens XD extract ...
MUNICH--(BUSINESS WIRE)--Definiens AG, which offers a unique approach to tissue diagnostics aimed at helping physicians improve treatment, said that it has closed a round of financing for € 15 million ...
MUNICH--(BUSINESS WIRE)--Definiens, the global leader in image analysis for digital pathology and diagnostics, today announced a new suite of Biomarker Datafication Services for oncology clinical ...
Wellington Partners, a leading pan-European venture capital firm, today announced that it acted as lead investor in a € 15 million growth financing round at Definiens AG, Munich, Germany. Wellington ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ultivue, a developer of tissue biomarker identification and quantification assays for translational and pathology research labs, and Definiens, a pioneer in ...
MUNICH, Germany, PARSIPPANY, N.J. and ANDOVER, Mass., Dec. 3 Definiens, the number one Enterprise Image Intelligence® company, and Visage Imaging® Inc., a wholly owned subsidiary of Pro Medicus Ltd.
Collaboration to bolster end-to-end services from assay development to confident informed clinical decision making MUNICH and KASSEL, Germany, June 20, 2019 /CNW/ -- Definiens, a leading international ...
MedImmune enters into an agreement to acquire the image analysis and data mining company. MedImmune, AstraZeneca’s global biologics research and development arm, has entered into an agreement to ...
Definiens XD framework will be used to build on ACD’s RNAscope biomarker analysis and diagnostics platform. Definiens will develop an image analysis application for Advanced Cell Diagnostics (ACD) ...
Definiens, the number one Enterprise Image Intelligence™ company, has announced the introduction of a new multi-dimensional image analysis platform. Software applications built on Definiens XD extract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results